Efficacy and safety of COVID-19 vaccines in older people
| dc.contributor.author | Soiza, Roy L | |
| dc.contributor.author | Scicluna, Chiara | |
| dc.contributor.author | Thomson, Emma C. | |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Evaluation | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2021-12-02T00:05:40Z | |
| dc.date.available | 2021-12-02T00:05:40Z | |
| dc.date.issued | 2021-03-01 | |
| dc.description | Declaration of Conflicts of Interest R.L.S. is a principal investigator in the Novavax COVID-19 vaccine trial. C.S. is a sub-investigator in the Novavax COVID-19 vaccine trial. E.C.T. has no conflicts of interest to declare. Views expressed are the authors’ own. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 5 | |
| dc.format.extent | 118293 | |
| dc.identifier | 180878035 | |
| dc.identifier | 5ba5679e-9e24-4eb2-aee0-8ad29bd109df | |
| dc.identifier | 33320183 | |
| dc.identifier | 85102657992 | |
| dc.identifier.citation | Soiza, R L, Scicluna, C & Thomson, E C 2021, 'Efficacy and safety of COVID-19 vaccines in older people', Age and Ageing, vol. 50, no. 2, afaa274, pp. 279–283. https://doi.org/10.1093/ageing/afaa274 | en |
| dc.identifier.doi | 10.1093/ageing/afaa274 | |
| dc.identifier.iss | 2 | en |
| dc.identifier.issn | 0002-0729 | |
| dc.identifier.other | ORCID: /0000-0002-1397-4272/work/84977585 | |
| dc.identifier.other | PubMedCentral: PMC7799251 | |
| dc.identifier.other | unpaywall: 10.1093/ageing/afaa274 | |
| dc.identifier.uri | https://hdl.handle.net/2164/17611 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85102657992&partnerID=8YFLogxK | en |
| dc.identifier.vol | 50 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Age and Ageing | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | coronavirus | en |
| dc.subject | SARS-Cov-2 | en |
| dc.subject | elderly | en |
| dc.subject | geriatrics | en |
| dc.subject | vaccines | en |
| dc.subject | Humans | en |
| dc.subject | Treatment Outcome | en |
| dc.subject | Frail Elderly | en |
| dc.subject | Patient Selection | en |
| dc.subject | SARS-CoV-2 | en |
| dc.subject | COVID-19/epidemiology | en |
| dc.subject | Patient Safety | en |
| dc.subject | Aged | en |
| dc.subject | COVID-19 Vaccines/adverse effects | en |
| dc.subject | Immunization Programs/methods | en |
| dc.subject | Geriatrics/methods | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Efficacy and safety of COVID-19 vaccines in older people | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Soiza_et_al_AA_EfficacyAndSafetyOf_AAM.pdf
- Size:
- 115.52 KB
- Format:
- Adobe Portable Document Format
